South San Francisco-based Harpoon Therapeutics is looking to tap into the white-hot IPO magic that has been one of the hallmarks of 2018 for the biotech industry. The company filed its registration statement with the U.S. Securities and Exchange Commission on Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,